Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-27 @ 1:43 AM
Study NCT ID:
NCT05394168
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-01
First Post:
2022-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-04
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-29
First Submit QC Date:
None
Study First Post Date:
2022-05-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-28
Last Update Post Date:
2024-04-01
Last Update Post Date Type:
ACTUAL